Total Funding
62
59
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
152687
FibRx Derm is offers development of decorin, an anti-scarring therapy, for Dystrophic Epidermolysis Bullosa.
Erkki Ruoslahti: Co-Founder
About the Company
FIBRX Derm is committed to the development of decorin, an anti-scarring therapy, for Dystrophic Epidermolysis Bullosa, a devastating, genetic, skin blistering disease. Decorin, a naturally occurring protein, binds collagen and facilitates the proper development, maintenance, and repair of structural components of the extracellular matrix. They are
developing a gel formulation of human recombinant Decorin, an engineered form of the natural anti-scarring protein, to promote healthy tissue regeneration and reduce excessive scarring.
